Emily M. Ko, M.D., M.S.C.R.
Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania Philadelphia, PA
Associate Fellowship Director, Division of Gynecologic Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
PAH Gynecologic Oncology Disease Team Co-Chair, Pennsylvania Hospital
Department: Obstetrics and Gynecology
Contact information
Department of Ob/Gyn
Division of Gynecologic Oncology
University of Pennsylvania Health System
Pennsylvania Hospital
800 Walnut Street, 10th Floor
Philadelphia, PA 19107
Division of Gynecologic Oncology
University of Pennsylvania Health System
Pennsylvania Hospital
800 Walnut Street, 10th Floor
Philadelphia, PA 19107
Office: 215-829-2345
Fax: 215-829-3365
Fax: 215-829-3365
Education:
A.B. (Magna Cum Laude with Highest Honors in Cognitive Neuroscience)
Harvard College, Cambridge, MA, 2000.
(American College of Pathology approved one-year fellowship.)
University of Massachusetts Medical School, Worcester, MA, 2003.
MD (Alpha Omega Alpha)
University of Massachusetts Medical School, Worcester, MA, 2005.
MSCR (Masters of Science in Clinical Research )
University of North Carolina Gillings School of Public Health, Chapel Hill, NC, 2013.
Permanent linkA.B. (Magna Cum Laude with Highest Honors in Cognitive Neuroscience)
Harvard College, Cambridge, MA, 2000.
(American College of Pathology approved one-year fellowship.)
University of Massachusetts Medical School, Worcester, MA, 2003.
MD (Alpha Omega Alpha)
University of Massachusetts Medical School, Worcester, MA, 2005.
MSCR (Masters of Science in Clinical Research )
University of North Carolina Gillings School of Public Health, Chapel Hill, NC, 2013.
Selected Publications
Ko E, Funk MJ, Clark L, Brewster W: Did GOG99 and Portec1 Change Clinical Practice in the United States? Gynecol Oncol 129(1):12-17, Apr 2013.Ko EM, Muto MG, Berkowitz RS, Feltmate CM: Robotic versus open radical hysterectomy: a comparative study at a single institution. Gynecol Oncol 111(3):425-30, Dec 2008.
Semere LG, Ko E, Johnson NR, Vitonis AF, Phang LJ, Cramer DW, Mutter GL: Endometrial intraepithelial neoplasia clinical correlates and outcomes. Obstet Gynecol 118(1):21-8, Jul 2011.
Ko EM, Stürmer T, Hong JL, Castillo WC, Bae-Jump V, Funk MJ: Metformin and the risk of endometrial cancer: A population-based cohort study. Gynecol Oncol 136(2):341-7, Feb 2015.
Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord Angeles A, Moore DT, Gehrig PA, Bae-Jump VL: The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. Gynecol Oncol 133(1):28-32, Apr 2014.
Clark LH, Jackson AL, Gehrig PA, Bae-Jump V, Van Le L, Ko EM: Adjuvant treatment and clinical trials in elderly with endometrial cancer: a time for change? Int J Gynecol Cancer 26(2):282-9, Feb 2016.
Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, Burger R, Kim S, Ko E: Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program. Int J Gynecol Cancer 27(3):581-587, Mar 2017.
Cory L, Latif N, Brensinger C, Zhang X, Giuntoli RL 2nd, Burger RA, Morgan M, Ko E: Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications. Obstet Gynecol 130(2):285-295, Aug 2017.
Cohn DE, Ko E, Meyer LA, Wright JD, Temkin SM, Foote J, Jones NL, Havrilesky LJ: The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. Gynecol Oncol 145(1):185-191, Apr 2017.
Haggerty A, Hagemann A,Barnett M, Thornquist M, Neuhouser M, Horowitz N, Colditz G, Sarwer DB, Ko E, Allison KC: A Randomized Controlled, Multi-Center Study of Technology-Based Weight Loss Interventions Among Endometrial Cancer Survivors. Obesity. Silver Spring, 25 (Suppl 2): S102-S108, Nov 2017.
Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF 3rd, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD: Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP). Gynecol Oncol 149(2): 232-240, May 2018.
Wright JD, Havrilesky LJ, Cohn DE, Huang Y, Rathbun J, Rice LW, Brown CL, Alvarez RD, Ko EM: Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model. Gynecol Oncol 149(2):241-47, May 2018.